These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 24977448

  • 1. [CXCR4: a new therapeutic target of the leukaemic cell? Role of the SDF-1/CXCR4 axis in acute myeloid leukaemia].
    Tavernier E, Aanei C, Solly F, Flandrin-Gresta P, Campos L, Guyotat D.
    Bull Cancer; 2014 Jun; 101(6):593-604. PubMed ID: 24977448
    [Abstract] [Full Text] [Related]

  • 2. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
    Ladikou EE, Chevassut T, Pepper CJ, Pepper AG.
    Br J Haematol; 2020 Jun; 189(5):815-825. PubMed ID: 32135579
    [Abstract] [Full Text] [Related]

  • 3. Targeting the microenvironment in acute myeloid leukemia.
    Rashidi A, Uy GL.
    Curr Hematol Malig Rep; 2015 Jun; 10(2):126-31. PubMed ID: 25921388
    [Abstract] [Full Text] [Related]

  • 4. Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia.
    Möhle R, Schittenhelm M, Failenschmid C, Bautz F, Kratz-Albers K, Serve H, Brugger W, Kanz L.
    Br J Haematol; 2000 Sep; 110(3):563-72. PubMed ID: 10997965
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A CXCR4 antagonist leads to tumor suppression by activation of immune cells in a leukemia-induced microenvironment.
    Han AR, Lee JY, Kim HJ, Min WS, Park G, Kim SH.
    Oncol Rep; 2015 Dec; 34(6):2880-8. PubMed ID: 26398122
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The role of stromal cell-derived factor and its receptor-CXCR4 in G-CSF-induced hematopoietic stem cell mobilization].
    Jin FY, Qiu LG, Li QC, Meng HX, Wang YF, Yu Z, Li Q, Han JL.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):98-102. PubMed ID: 17650669
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Stromal cell-derived factor-1 (SDF-1) as a target in liver diseases.
    Liepelt A, Tacke F.
    Am J Physiol Gastrointest Liver Physiol; 2016 Aug 01; 311(2):G203-9. PubMed ID: 27313175
    [Abstract] [Full Text] [Related]

  • 17. Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside.
    Cho BS, Kim HJ, Konopleva M.
    Korean J Intern Med; 2017 Mar 01; 32(2):248-257. PubMed ID: 28219003
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. CXCL12 and CXCR4 in bone marrow physiology.
    Moll NM, Ransohoff RM.
    Expert Rev Hematol; 2010 Jun 01; 3(3):315-22. PubMed ID: 21082982
    [Abstract] [Full Text] [Related]

  • 20. The role of SDF-1-CXCR4/CXCR7 axis in biological behaviors of adipose tissue-derived mesenchymal stem cells in vitro.
    Li Q, Zhang A, Tao C, Li X, Jin P.
    Biochem Biophys Res Commun; 2013 Nov 22; 441(3):675-80. PubMed ID: 24184476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.